Singapore markets closed
Straits Times Index
3,322.62 +14.72 (+0.45%) S&P 500
5,317.96 +10.95 (+0.21%) Dow
39,475.40 -195.64 (-0.49%) Nasdaq
16,921.27 +119.73 (+0.71%) Bitcoin USD
68,186.09 -1,311.39 (-1.89%) CMC Crypto 200
1,471.45 -31.22 (-2.08%)
SinoMab BioScience Limited (3681.HK)
HKSE - HKSE Delayed price. Currency in HKD
Add to watchlist
At close: 03:50PM HKT
Currency in HKD
Valuation measures4
| Market cap (intra-day) | 2.02B |
| Enterprise value | 2.25B |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG ratio (5-yr expected) | N/A |
| Price/sales (ttm) | 1.28k |
| Price/book (mrq) | 6.34 |
| Enterprise value/revenue | 1.53k |
| Enterprise value/EBITDA | -5.43 |
Trading information
Stock price history
| Beta (5Y monthly) | 0.72 |
| 52-week change 3 | 1.65% |
| S&P500 52-week change 3 | 27.84% |
| 52-week high 3 | 1.950 |
| 52-week low 3 | 1.030 |
| 50-day moving average 3 | 1.693 |
| 200-day moving average 3 | 1.437 |
Share statistics
| Avg vol (3-month) 3 | 208.5k |
| Avg vol (10-day) 3 | 88.92k |
| Shares outstanding 5 | 1.09B |
| Implied shares outstanding 6 | 1.09B |
| Float 8 | 298.81M |
| % held by insiders 1 | 42.74% |
| % held by institutions 1 | 19.50% |
| Shares short 4 | N/A |
| Short ratio 4 | N/A |
| Short % of float 4 | N/A |
| Short % of shares outstanding 4 | N/A |
| Shares short (prior month ) 4 | N/A |
Dividends & splits
| Forward annual dividend rate 4 | N/A |
| Forward annual dividend yield 4 | N/A |
| Trailing annual dividend rate 3 | 0.00 |
| Trailing annual dividend yield 3 | 0.00% |
| 5-year average dividend yield 4 | N/A |
| Payout ratio 4 | 0.00% |
| Dividend date 3 | N/A |
| Ex-dividend date 4 | N/A |
| Last split factor 2 | N/A |
| Last split date 3 | N/A |
Financial highlights
Currency in CNY.Fiscal year
| Fiscal year ends | 31 Dec 2023 |
| Most-recent quarter (mrq) | 31 Dec 2023 |
Profitability
| Profit margin | 0.00% |
| Operating margin (ttm) | 2,947.04% |
Management effectiveness
| Return on assets (ttm) | -15.46% |
| Return on equity (ttm) | -60.39% |
Income statement
| Revenue (ttm) | 4.39M |
| Revenue per share (ttm) | 0.00 |
| Quarterly revenue growth (yoy) | N/A |
| Gross profit (ttm) | N/A |
| EBITDA | -210.44M |
| Net income avi to common (ttm) | -243.11M |
| Diluted EPS (ttm) | -0.260 |
| Quarterly earnings growth (yoy) | N/A |
Balance sheet
| Total cash (mrq) | 237.53M |
| Total cash per share (mrq) | 0.23 |
| Total debt (mrq) | 450.81M |
| Total debt/equity (mrq) | 152.51% |
| Current ratio (mrq) | 1.57 |
| Book value per share (mrq) | 0.29 |
Cash flow statement
| Operating cash flow (ttm) | -133.85M |
| Levered free cash flow (ttm) | -244.57M |
© 2024 Yahoo. All rights reserved.